-
EU Set to Investigate China’s Medical Device Procurement Practices Amid Fairness Concerns
•
The European Union (EU) is reportedly gearing up to launch an investigation into medical device procurement practices in China, as reported by Bloomberg News. The inquiry will focus on whether domestic suppliers are being unfairly favored in the procurement process. Sources indicate that the investigation could commence this month and…
-
Ningbo Menovo Partners with University of Michigan to Develop GLP-1 Delivery System
•
Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538), a China-based company, has announced a strategic partnership with the University of Michigan in the United States. Financial details of the collaboration remain undisclosed. The partnership will focus on developing an innovative delivery system for glucagon-like peptide-1 (GLP-1) drug targets, with the University…
-
Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online
•
Vazyme Biotech Co., Ltd (SHA: 688105), based in China, has entered into a strategic partnership with Shanghai Yufang Medical Technology (Group) Co., Ltd to enhance their collaboration in the screening and testing sector. Under the terms of the agreement, the two companies will leverage their respective strengths to jointly promote…
-
Keymed Biosciences Achieves First Dosing in Global Phase III Trial for Claudin 18.2 Targeting ADC
•
Keymed Biosciences Inc., (HKG: 2162), a biopharmaceutical company based in China, has announced the completion of the first dosing in a global multi-center Phase III study for its Claudin 18.2 (CLDN18.2)-targeted antibody-drug conjugate (ADC) CMG901 (AZD0901). The ADC is being evaluated as a treatment for advanced solid tumors in the…
-
89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China
•
U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and Manufacturing Organization (CDMO) BiBio Biopharma Engineering to construct an API facility in China. The facility will supply the active pharmaceutical ingredient (API) for 89bio’s lead pipeline candidate, pegozafermin, an investigational FGF21 analog currently in Phase…
-
Shanghai Electric Group and Siemens Healthineers Unveil Ultramarine Series Medical Imaging Devices
•
Shanghai Electric Group, a major player in China’s electrical equipment industry, has partnered with Siemens Healthineers, the German medical technology giant, to launch the Ultramarine series of medical imaging products. The new lineup features three domestically produced medical imaging devices: the Ultramarine 1.5T MRI, Ultramarine 128 CT, and Ultramarine 32…
-
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
•
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was a significant event for JD Healthcare, a subsidiary of China’s e-commerce giant JD.com (NASDAQ: JD). The company announced a series of strategic partnerships with prominent medical device firms, including Yuyue Medical, Omron, Cofoe Medical, Philips,…
-
FDA Advisory Committee Backs MRD as Accelerated Approval Endpoint for Multiple Myeloma
•
The Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) has unanimously voted to recommend the use of minimal residual disease (MRD) as an accelerated approval endpoint in clinical trials for multiple myeloma. The 12-0 vote by the committee, which serves as a recommendation to the…
